{"id":16,"date":"2026-08-17T12:53:22","date_gmt":"2026-08-17T12:53:22","guid":{"rendered":"https:\/\/peptide-doc.com\/learn\/bpc-157\/"},"modified":"2026-09-02T19:41:50","modified_gmt":"2026-09-02T19:41:50","slug":"bpc-157","status":"publish","type":"learn_article","link":"https:\/\/peptide-doc.com\/de\/learn\/bpc-157\/","title":{"rendered":"BPC-157"},"content":{"rendered":"
\nMETA-TITLE:<\/strong> [TODO: BPC-157 \u2014 Healing Peptide Research Profile | Brand]
\nMETA-DESC:<\/strong> [TODO: Comprehensive BPC-157 research profile \u2014 gastric pentadecapeptide mechanism, tissue repair studies, dosing, safety.]\n<\/div>\n

[TODO]<\/span> Hook \u2014 BPC-157 as the most researched healing peptide, gastric juice-derived, broad tissue repair potential across 100+ studies<\/p>\n

[IMAGE: BPC-157 molecular structure \u2014 15 amino acid sequence visualization]<\/div>\n

What is BPC-157?<\/h2>\n
    \n
  • [TODO]<\/span> Full name \u2014 Body Protection Compound-157, pentadecapeptide (15 amino acids)<\/li>\n
  • [TODO]<\/span> Origin \u2014 isolated from human gastric juice, part of larger BPC protein<\/li>\n
  • [TODO]<\/span> Molecular weight \u2014 1419.53 Da<\/li>\n
  • [TODO]<\/span> Stability \u2014 stable in gastric acid (unique for peptides), no carrier needed<\/li>\n
  • [TODO]<\/span> Research scope \u2014 100+ published studies, mostly animal models<\/li>\n<\/ul>\n

    Mechanism of Action<\/h2>\n
    [IMAGE: Diagram of BPC-157 pathways \u2014 NO system, VEGF, FAK-paxillin, GH receptor interaction]<\/div>\n
      \n
    • [TODO]<\/span> Nitric oxide system \u2014 modulates eNOS, promotes vasodilation and blood flow to injured tissue<\/li>\n
    • [TODO]<\/span> Angiogenesis \u2014 VEGF upregulation, new blood vessel formation in damaged areas<\/li>\n
    • [TODO]<\/span> FAK-paxillin pathway \u2014 cell migration and tissue repair signaling<\/li>\n
    • [TODO]<\/span> Growth hormone receptor interaction \u2014 upregulates GH receptor expression<\/li>\n
    • [TODO]<\/span> Anti-inflammatory \u2014 reduces TNF-alpha, modulates cytokine profile<\/li>\n
    • [TODO]<\/span> GI protection \u2014 cytoprotective in gastric\/intestinal mucosa<\/li>\n<\/ul>\n

      Research Highlights<\/h2>\n
        \n
      • [TODO]<\/span> Tendon\/ligament \u2014 accelerated healing in Achilles tendon transection (rat)<\/li>\n
      • [TODO]<\/span> Muscle \u2014 improved recovery after crush injury, laceration models<\/li>\n
      • [TODO]<\/span> GI tract \u2014 gastric ulcer healing, IBD models, fistula repair<\/li>\n
      • [TODO]<\/span> Bone \u2014 enhanced fracture healing, osteogenic activity<\/li>\n
      • [TODO]<\/span> Neuroprotection \u2014 peripheral nerve repair, dopaminergic system interaction<\/li>\n
      • [TODO]<\/span> Limitation \u2014 no completed human clinical trials to date<\/li>\n<\/ul>\n

        Dosing Protocols (Research Context)<\/h2>\n
          \n
        • [TODO]<\/span> Typical research dose \u2014 200-800mcg\/day (subcutaneous or oral)<\/li>\n
        • [TODO]<\/span> Systemic vs local \u2014 SC near injury site vs systemic injection vs oral<\/li>\n
        • [TODO]<\/span> Duration \u2014 4-6 week protocols common in animal literature<\/li>\n
        • [TODO]<\/span> Reconstitution \u2014 bacteriostatic water, store 2-8\u00b0C, use within 4 weeks<\/li>\n<\/ul>\n

          Safety & Considerations<\/h2>\n
            \n
          • [TODO]<\/span> Toxicity data \u2014 no reported LD50, no organ toxicity in animal studies<\/li>\n
          • [TODO]<\/span> Side effects \u2014 minimal reported in animal literature<\/li>\n
          • [TODO]<\/span> Limitations \u2014 predominantly animal data, lack of human RCTs<\/li>\n
          • [TODO]<\/span> WADA status \u2014 listed on prohibited substance list (S0 category)<\/li>\n<\/ul>\n

            Frequently Asked Questions<\/h2>\n
            [FAQ: Can BPC-157 be taken orally or is injection required?]<\/div>\n
            [FAQ: How does BPC-157 compare to TB-500 for tissue repair?]<\/div>\n
            [FAQ: What is the shelf life after reconstitution?]<\/div>\n
            [FAQ: Are there any human clinical trials for BPC-157?]<\/div>\n
            [FAQ: Does BPC-157 interact with other peptides?]<\/div>\n

            Related Products<\/h2>\n

            [TODO]<\/span> Link to BPC-157 product page + Healing & Recovery category<\/p>\n","protected":false},"excerpt":{"rendered":"

            [META-DESC TODO: BPC-157 research profile \u2014 gastric pentadecapeptide, healing mechanisms, studies, protocols, safety.]<\/p>\n","protected":false},"featured_media":0,"template":"","learn_category":[3],"class_list":["post-16","learn_article","type-learn_article","status-publish","hentry","learn_category-healing-recovery"],"_links":{"self":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article\/16","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article"}],"about":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/types\/learn_article"}],"version-history":[{"count":1,"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article\/16\/revisions"}],"predecessor-version":[{"id":39,"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article\/16\/revisions\/39"}],"wp:attachment":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/media?parent=16"}],"wp:term":[{"taxonomy":"learn_category","embeddable":true,"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_category?post=16"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}